Uncertainty on the effectiveness and safety of rivaroxaban in premenopausal women with atrial fibrillation: empirical evidence needed

Uncertainty on the effectiveness and safety of rivaroxaban in premenopausal women with atrial fibrillation: empirical evidence needed

Abstract Background Novel anticoagulations (NOACs) are increasingly prescribed for the prevention of stroke in premenopausal women with atrial fibrillation. Small studies suggest NOACs are associated with a higher risk of abnormal uterine bleeds than vitamin K antagonists (VKAs). Because there is no...

Full description

Bibliographic Details
Main Authors: Herbert J. A. Rolden, Angela H. E. M. Maas, Gert Jan van der Wilt, Janneke P. C. Grutters
Format: Article
Language:English
Published: BMC 2017-10-01
Series:BMC Cardiovascular Disorders
Subjects:
Abnormal uterine bleeding
Atrial fibrillation
Premenopausal women
Rivaroxaban
Value of information
Vitamin K antagonists
Online Access:http://link.springer.com/article/10.1186/s12872-017-0692-1

Internet

http://link.springer.com/article/10.1186/s12872-017-0692-1

Similar Items